Oropharyngeal Cancers Completed Phase 2 Trials for Cetuximab (DB00002)

Also known as: Oropharyngeal Cancer / Cancer of Oropharnyx

IndicationStatusPhase
DBCOND0042409 (Oropharyngeal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01435252A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On CetuximabTreatment